Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.31 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15064040 | 0.72 | ALDH1A1 (0.32) | — | |
| SCHEMBL5581285 | 0.71 | — | — | |
| SCHEMBL10691257 | 0.70 | — | — | |
| SCHEMBL11417421 | 0.70 | CYP2A6 (0.36) | — | |
| SCHEMBL15064036 | 0.69 | — | — | |
| SCHEMBL3689561 | 0.69 | CYP3A4 (0.31) | CYP3A4 | |
| SCHEMBL512915 | 0.67 | — | — | |
| SCHEMBL11784137 | 0.64 | — | — | |
| SCHEMBL11219358 | 0.63 | GRIN2D (0.52) | CYP3A4GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL14143885 | 0.63 | HPGD (0.48) | CYP3A4GRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1125979-B1 | Polymer blends | INEOS EUROPE LTD (GB) | 2006-11-29 | — | — | EP | claimed |
| CN-1216079-C | Polymersation catalysts | BP CHEM INT LTD (GB) | 2005-08-24 | — | — | CN | claimed |
| US-6828398-B2 | Transition metal complex containing pyrimidine or pyrazine compound used as polymerization catalysts for alpha-olefins | BP CHEMICALS LIMITED (GB) | 2004-12-07 | — | — | US | claimed |
| EP-1062250-B1 | POLYMERISATION CATALYSTS | BP CHEM INT LTD (GB) | 2004-07-14 | — | — | EP | claimed |
| US-6608140-B2 | Polymer blends | BP CHEMICALS LIMITED (GB) | 2003-08-19 | — | — | US | claimed |
| US-20030100689-A1 | Polymerisation catalyst | BP CHEMICALS LIMITED (GB) | 2003-05-29 | — | — | US | claimed |
| EP-1265935-A1 | POLYMERISATION CATALYST | BP Chemicals Limited (GB) | 2002-12-18 | — | — | EP | claimed |
| EP-1102777-B1 | PREPARATION OF POLYMERISATION CATALYSTS | BP CHEM INT LTD (GB) | 2002-12-18 | — | — | EP | claimed |
| EP-1015501-B1 | POLYMERISATION CATALYSTS | BP CHEM INT LTD (GB) | 2002-05-29 | — | — | EP | claimed |
| US-20020004560-A1 | Polymer blends | INEOS SALES (UK) LIMITED (GB) | 2002-01-10 | — | — | US | claimed |
| WO-2001068726-A1 | ATOM TRANSFER RADICAL POLYMERISATION CATALYST | BP CHEMICALS LIMITED (GB) | 2001-09-20 | — | — | WO | claimed |
| EP-1125979-A1 | Polymer blends | BP Chemicals Limited (GB) | 2001-08-22 | — | — | EP | claimed |
| WO-2001058966-A1 | POLYMERISATION CATALYST | BP CHEMICALS LIMITED (GB) | 2001-08-16 | — | — | WO | claimed |
| WO-2001012684-A1 | POLYMERISATION PROCESS | BP CHEMICALS LIMITED (GB) | 2001-02-22 | — | — | WO | claimed |
| WO-2000069869-A1 | POLYMERISATION CATALYSTS | BP CHEMICALS LIMITED (GB) | 2000-11-23 | — | — | WO | claimed |
| WO-2000058320-A1 | PYRIDINE.IMINE POLYMERISATION CATALYSTS | BP CHEMICALS LIMITED (GB) | 2000-10-05 | — | — | WO | claimed |
| EP-2308815-B1 | CHAIN GROWTH REACTION PROCESS | INEOS SALES UK LTD (GB) | 2018-11-14 | — | — | EP | disclosed |
| EP-1910426-B1 | DIENE POLYMERISATION | INEOS SALES (UK) LTD (GB) | 2018-01-03 | — | — | EP | disclosed |
| EP-1062250-A1 | POLYMERISATION CATALYSTS | BP Chemicals Limited (GB) | 2000-12-27 | — | — | EP | disclosed |
| WO-1999046303-A1 | POLYMERISATION CATALYSTS | BP CHEMICALS LIMITED (GB) | 1999-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030100689-A1 | Polymerisation catalyst | NR1H2, NR1H3, MT-CO1 | CYP3A4 564/4885GRIN2D 1493/4885GRIN3B 942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.